These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 9764589
1. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. Dolan K, Garde J, Gosney J, Sissons M, Wright T, Kingsnorth AN, Walker SJ, Sutton R, Meltzer SJ, Field JK. Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589 [Abstract] [Full Text] [Related]
2. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, Rowley H, Taylor K, Whittaker J, Howard P. Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465 [Abstract] [Full Text] [Related]
3. Allelotype analysis of esophageal squamous cell carcinoma. Shibagaki I, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K. Cancer Res; 1994 Jun 01; 54(11):2996-3000. PubMed ID: 8187088 [Abstract] [Full Text] [Related]
4. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Kersemaekers AM, Hermans J, Fleuren GJ, van de Vijver MJ. Br J Cancer; 1998 Jun 01; 77(2):192-200. PubMed ID: 9460988 [Abstract] [Full Text] [Related]
5. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. Chang HJ, Kim SW, Kim YT, Kim WH. Mod Pathol; 1999 Aug 01; 12(8):763-9. PubMed ID: 10463477 [Abstract] [Full Text] [Related]
6. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer. Field JK, Neville EM, Stewart MP, Swift A, Liloglou T, Risk JM, Ross H, Gosney JR, Donnelly RJ. Br J Cancer; 1996 Dec 01; 74(12):1968-74. PubMed ID: 8980398 [Abstract] [Full Text] [Related]
7. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer. Pan H, Califano J, Ponte JF, Russo AL, Cheng KH, Thiagalingam A, Nemani P, Sidransky D, Thiagalingam S. Cancer Res; 2005 Mar 01; 65(5):1664-9. PubMed ID: 15753360 [Abstract] [Full Text] [Related]
8. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. Galipeau PC, Prevo LJ, Sanchez CA, Longton GM, Reid BJ. J Natl Cancer Inst; 1999 Dec 15; 91(24):2087-95. PubMed ID: 10601379 [Abstract] [Full Text] [Related]
9. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM, Børresen AL. Genes Chromosomes Cancer; 1992 Mar 15; 4(2):113-21. PubMed ID: 1373310 [Abstract] [Full Text] [Related]
10. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan. Sheu JC, Lin YW, Chou HC, Huang GT, Lee HS, Lin YH, Huang SY, Chen CH, Wang JT, Lee PH, Lin JT, Lu FJ, Chen DS. Br J Cancer; 1999 May 15; 80(3-4):468-76. PubMed ID: 10408855 [Abstract] [Full Text] [Related]
11. Loss of heterozygosity at microsatellite marker sites for tumour suppressor genes in oesophageal adenocarcinoma. Morgan RJ, Newcomb PV, Bailey M, Hardwick RH, Alderson D. Eur J Surg Oncol; 1998 Feb 15; 24(1):34-7. PubMed ID: 9542513 [Abstract] [Full Text] [Related]
14. An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway. Yamamoto S, Tsuda H, Suzuki K, Takano M, Tamai S, Matsubara O. Virchows Arch; 2009 Sep 15; 455(3):261-70. PubMed ID: 19655165 [Abstract] [Full Text] [Related]
15. Loss of heterozygosity analysis in uterine cervical adenocarcinoma. Miyai K, Furugen Y, Matsumoto T, Iwabuchi K, Hirose S, Kinoshita K, Fujii H. Gynecol Oncol; 2004 Jul 15; 94(1):115-20. PubMed ID: 15262128 [Abstract] [Full Text] [Related]
16. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer. Dunn J, Garde J, Dolan K, Gosney JR, Sutton R, Meltzer SJ, Field JK. Oncogene; 1999 Jan 28; 18(4):987-93. PubMed ID: 10023674 [Abstract] [Full Text] [Related]
17. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. Grebe SK, McIver B, Hay ID, Wu PS, Maciel LM, Drabkin HA, Goellner JR, Grant CS, Jenkins RB, Eberhardt NL. J Clin Endocrinol Metab; 1997 Nov 28; 82(11):3684-91. PubMed ID: 9360526 [Abstract] [Full Text] [Related]
18. Human gastric adenocarcinoma allelotype on chromosomes 17 and 18. Yu JC, Zhou H, Bai J, Yu Y, Geng JS, Qi JP, Fu SB. J Int Med Res; 2008 Nov 28; 36(2):279-88. PubMed ID: 18380938 [Abstract] [Full Text] [Related]
19. Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma. Swift A, Risk JM, Kingsnorth AN, Wright TA, Myskow M, Field JK. Br J Cancer; 1995 May 28; 71(5):995-8. PubMed ID: 7734326 [Abstract] [Full Text] [Related]
20. Frequent loss of copy number on the long arm of chromosome 21 in human esophageal squamous cell carcinoma. Mayama T, Fukushige S, Shineha R, Nishihira T, Satomi S, Horii A. Int J Oncol; 2000 Aug 28; 17(2):245-52. PubMed ID: 10891531 [Abstract] [Full Text] [Related] Page: [Next] [New Search]